• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用高亲和力嵌合标签招募免疫系统对抗致病细菌

Recruiting the Immune System against Pathogenic Bacteria Using High-Affinity Chimeric Tags.

作者信息

Belo Yael, Malach Einav, Hayouka Zvi

机构信息

Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agricultural, Food & Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel.

出版信息

Bioconjug Chem. 2024 Nov 20;35(11):1716-1722. doi: 10.1021/acs.bioconjchem.4c00291. Epub 2024 Oct 14.

DOI:10.1021/acs.bioconjchem.4c00291
PMID:39401419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11583208/
Abstract

The immune system plays a critical role in protecting the host against pathogens. However, mechanisms for evading the immune system have evolved in pathogens, altering their surface proteins or causing the expression of enzymes that interfere with the immune response. These strategies cause pathogens to escape detection and destruction by the immune system, thereby inducing severe infections. Thus, there is a critical need to develop new chemical tools to recruit the immune system against evading pathogens. Here, we describe a novel strategy for targeting pathogens, by labeling them with a chimeric agent that comprises a peptide bacterial binder, conjugated to an immune-protein tag that is recognizable by the complement system, thereby recruiting the immune system against the targeted pathogen. The chimeric tag was developed by conjugating the peptide bacterial binder with the C3b complement system activating protein. We showed that the chimeric C3b tag preserved its activity and was able to bind the C5 complement protein with strong binding affinity. Using this approach, we have demonstrated that the chimeric agent was able to eradicate 90% of complement-resistant bacterial cells. By showing enhancement of complement sensitivity in complement-resistant pathogens, this work demonstrates the basis for a new therapeutic approach for targeting pathogenic bacteria, which could open a new era in the development of selective and effective antimicrobial agents.

摘要

免疫系统在保护宿主抵御病原体方面发挥着关键作用。然而,病原体已经进化出逃避免疫系统的机制,改变其表面蛋白或导致干扰免疫反应的酶的表达。这些策略使病原体能够逃避免疫系统的检测和破坏,从而引发严重感染。因此,迫切需要开发新的化学工具来调动免疫系统对抗逃避的病原体。在此,我们描述了一种针对病原体的新策略,通过用一种嵌合剂标记它们,该嵌合剂包含一种肽类细菌结合剂,与补体系统可识别的免疫蛋白标签偶联,从而调动免疫系统对抗靶向病原体。该嵌合标签是通过将肽类细菌结合剂与C3b补体系统激活蛋白偶联而开发的。我们表明,嵌合C3b标签保留了其活性,并能够以强结合亲和力结合C5补体蛋白。使用这种方法,我们证明了嵌合剂能够根除90%的补体抗性细菌细胞。通过显示补体抗性病原体中补体敏感性的增强,这项工作证明了一种针对病原菌的新治疗方法的基础,这可能会开启选择性和有效抗菌剂开发的新纪元。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/7b6e0020e4d7/bc4c00291_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/3996bc0fcf1a/bc4c00291_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/6019c054a841/bc4c00291_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/63a7a42ae7ce/bc4c00291_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/1961022247b5/bc4c00291_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/7b6e0020e4d7/bc4c00291_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/3996bc0fcf1a/bc4c00291_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/6019c054a841/bc4c00291_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/63a7a42ae7ce/bc4c00291_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/1961022247b5/bc4c00291_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f17d/11583208/7b6e0020e4d7/bc4c00291_0005.jpg

相似文献

1
Recruiting the Immune System against Pathogenic Bacteria Using High-Affinity Chimeric Tags.利用高亲和力嵌合标签招募免疫系统对抗致病细菌
Bioconjug Chem. 2024 Nov 20;35(11):1716-1722. doi: 10.1021/acs.bioconjchem.4c00291. Epub 2024 Oct 14.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD003543. doi: 10.1002/14651858.CD003543.pub3.
7
Identification of an antibiotic from an HTS targeting EF-Tu:tRNA interaction: a prospective topical treatment for MRSA skin infections.从针对延伸因子 Tu(EF-Tu)与转运 RNA(tRNA)相互作用的高通量筛选中鉴定出一种抗生素:一种针对耐甲氧西林金黄色葡萄球菌(MRSA)皮肤感染的前瞻性局部治疗方法。
Appl Environ Microbiol. 2025 Jan 31;91(1):e0204624. doi: 10.1128/aem.02046-24. Epub 2024 Dec 23.
8
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
9
exploits host- and bacterial-derived β-alanine for replication inside host macrophages.利用宿主和细菌来源的β-丙氨酸在宿主巨噬细胞内进行复制。
Elife. 2025 Jun 19;13:RP103714. doi: 10.7554/eLife.103714.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

1
Integrative genomic analysis identifies novel causal genes of Hodgkin's and non-Hodgkin's lymphoma.综合基因组分析确定了霍奇金淋巴瘤和非霍奇金淋巴瘤的新致病基因。
Discov Oncol. 2025 Jul 13;16(1):1324. doi: 10.1007/s12672-025-03101-1.

本文引用的文献

1
Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1.经纯化的补体 C3b 通过补体受体 1 触发人中性粒细胞的吞噬作用和激活。
Sci Rep. 2023 Jan 6;13(1):274. doi: 10.1038/s41598-022-27279-4.
2
Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.从 ICU COVID-19 患者的红细胞上获得的 C3b/C4b 受体 (CR1、CD35) 减少和 C4d 沉积增加。
Immunobiology. 2021 May;226(3):152093. doi: 10.1016/j.imbio.2021.152093. Epub 2021 May 9.
3
Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity.
补体在 C3 或 C5 水平的抑制:持续的末端途径活性的机制原因。
Blood. 2021 Jan 28;137(4):443-455. doi: 10.1182/blood.2020005959.
4
An Irreversible Inhibitor to Probe the Role of Cysteine Protease SpeB in Evasion of Host Complement Defenses.一种不可逆抑制剂,用于研究半胱氨酸蛋白酶 SpeB 在逃避宿主补体防御中的作用。
ACS Chem Biol. 2020 Aug 21;15(8):2060-2069. doi: 10.1021/acschembio.0c00191. Epub 2020 Jul 28.
5
The role of O-polysaccharide chain and complement resistance of Escherichia coli in mammary virulence.大肠杆菌 O-多糖链和补体抗性在乳腺毒力中的作用。
Vet Res. 2020 Jun 15;51(1):77. doi: 10.1186/s13567-020-00804-x.
6
Multivalent Antibody-Recruiting Macromolecules: Linking Increased Binding Affinity with Enhanced Innate Immune Killing.多价抗体募集大分子:提高结合亲和力与增强固有免疫杀伤相结合。
Chembiochem. 2020 Nov 2;21(21):3036-3043. doi: 10.1002/cbic.202000261. Epub 2020 Jul 10.
7
Clinical promise of next-generation complement therapeutics.下一代补体治疗药物的临床前景。
Nat Rev Drug Discov. 2019 Sep;18(9):707-729. doi: 10.1038/s41573-019-0031-6. Epub 2019 Jul 19.
8
Role of O-Antigen in Response to Mechanical Stress of the E. coli Outer Membrane: Insights from Coarse-Grained MD Simulations.O 抗原在大肠杆菌外膜应对机械应力中的作用:粗粒 MD 模拟的见解。
J Phys Chem B. 2019 May 2;123(17):3567-3575. doi: 10.1021/acs.jpcb.8b12168. Epub 2019 Apr 23.
9
Antimicrobial random peptide cocktails: a new approach to fight pathogenic bacteria.抗菌随机肽鸡尾酒:一种对抗致病菌的新方法。
Chem Commun (Camb). 2019 Feb 12;55(14):2007-2014. doi: 10.1039/c8cc09961h.
10
Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.补体与细菌感染:从分子机制到治疗应用。
J Innate Immun. 2018;10(5-6):455-464. doi: 10.1159/000491439. Epub 2018 Aug 27.